Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) SHH

10.08

+0.02(+0.20%)

Updated at December 05 10:15AM

Currency In CNY

Valuation

Market Cap10.9B
Enterprise Value12.7B
P/E Ratio-28.41
PEG Ratio0.03
Price/Sales Ratio5.93
Price/Book Ratio1.3
Enterprise/Revenue7.87
Enterprise/EBITDA-72.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.21
Operating Margin-0.23

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.04

Income Statement

Revenue2.7B
Revenue/Share1.7
Gross Profit1.37B
EBITDA756.94M
Net Income438.22M
Diluted EPS0.47

Balance Sheet

Total Cash204.28M
Total Cash/Share0.22
Total Debt3.3B
Total Debt/Equity0.45
Current Ratio1.76
Book Value Per Share7.76

Price History

52-Week Change-15.11
52-Week High13.48
52-Week Low9.9
Moving Average 50 Days11.24
Moving Average 200 Days11.44

Statistics

Average Volume8.74M
Shares Outstanding940.4M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.15
Trailing Annual Dividend Yield1.49
Payout Ratio-0.32
Last Split Factor2:1
Last Split DateJune 13, 2016